Ireland, a long-standing Gavi donor since 2002, strongly supports the Alliance’s mission to expand access to life-saving vaccines for children in the world’s lowest-income and most fragile countries. This commitment reflects Ireland’s broader development priorities, including reducing health inequalities, strengthening health systems and ensuring that the most vulnerable communities are not left behind.
Ireland has steadily increased its financial support to Gavi over successive replenishment periods. It pledged €15 million (US$ 16.8 million) for the 2016–2020 strategic period, increased this to €18 million (US$ 19.8 million) for 2021–2025 and provided a total of €14 million (US$15.5 million) to the Gavi COVAX Advance Market Commitment (AMC) to support equitable access to COVID-19 vaccines. Ireland also joined other Team Europe partners in supporting the launch of the African Vaccine Manufacturing Accelerator (AVMA) in 2024 by committing €750,000 (US$ 710,000), helping to strengthen sustainable vaccine manufacturing capacity across Africa.
Most recently, at the Gavi 6.0 replenishment in June 2025, Ireland pledged €21.6 million (US$ 25.6 million) for the 2026–2030 period, representing a further 20% increase in support, and reaffirming its commitment to immunisation, global health security and protecting children from vaccine-preventable diseases.
As of 30 June 2024
Proceeds are the funds that Gavi receives from donor commitments, either through direct donor payments, funding raised in advance against future donor pledges through IFFIm, or AMC funds released by the World Bank.
Click on Direct, IFFIm, AMC or Matching Fund in the above key to toggle their data on the graph, click again to show the data
Notes:
Direct Contributions (including Matching Fund)
Received contributions: non-US$ contributions for 2000–2023 and Q1-Q2 2024 are expressed in US$ equivalents using the exchange rates on the dates of receipt. For 2014–2023 and Q1-Q2 2024, where contributions were hedged to mitigate currency risk exposure, these have been expressed using the rates applicable to the hedge agreement.
Future contributions (for pledges made prior to the June 2020 donor pledging conference): non-US$ direct contribution and Gavi Matching Fund pledges for Q3-Q4 2024 and for years 2025 and beyond are expressed in US$ equivalents using the applicable “forecast rates” from Bloomberg as of 30 June 2024 or using the rates applicable to any hedge agreement in place.
Future contributions (for pledges at the June 2020 donor pledging conference): non-US$ direct contribution and Gavi Matching Fund pledges for Q3-Q4 2024 and for years 2025 and beyond are expressed in US$ equivalents using the “spot rates” from Refinitiv as at 30 June 2024 or using the rates applicable to any hedge agreement in place.
IFFIm contributions
Received contributions: non-US$ contributions for 2000–2023 and for Q1-Q2 2024 are expressed in US$ equivalents as confirmed by the World Bank Group’s International Bank for Reconstruction and Development (IBRD).
Future contributions: non-US$ contributions for Q3-Q4 2024 and for years 2025 and beyond are expressed in US$ equivalents as follows:
General notes regarding IFFIm contributions:
Due to IFFIm’s nature as a frontloading vehicle, yearly contributions paid into IFFIm can differ significantly from yearly proceeds transferred to Gavi.
While IFFIm grants are irrevocable and legally binding, they are subject to a Grant Payment Condition that can potentially reduce the donor’s amount due, in the event that a Gavi-supported programme country is in protracted arrears with the International Monetary Fund (IMF). Since 29 June 2021, no reduction applies, as all countries from the reference portfolio have cleared their arrears with the IMF.